Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05896189 · ClinicalTrials.gov registry record · NA
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
A NA study of Breast Cancer and Cognitive Impairments, sponsored by NRG Oncology.
- Recruiting
- Registry status
- NA
- Development phase
- 386
- Enrollment target
- 20
- Study locations
NCT05896189 is a NA study of Breast Cancer and Cognitive Impairments that is actively recruiting participants, run by NRG Oncology. The registered enrollment target is 386 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 20 study locations across 3 states.
The verdict
NCT05896189, a NA study of Breast Cancer and Cognitive Impairments, is actively recruiting participants, sponsored by NRG Oncology.
- RECRUITING
- Registry status
- NA
- Development phase
- 386 participants
- Enrollment target
- 20
- Study locations
Study Summary
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Conditions Studied
Interventions
- BEHAVIORAL Arm 1: Computerized Cognitive Training-Global Stimulation Games
- BEHAVIORAL Arm 2: Computerized Cognitive Training-Neuroplasticity Games
Study Locations (20)
Arizona
- Arizona Center for Cancer Care - Gilbert - Gilbert
- CTCA at Western Regional Medical Center - Goodyear
- Arizona Center for Cancer Care-Peoria - Peoria
- Cancer Center at Saint Joseph's - Phoenix
- Arizona Center for Cancer Care - Biltmore - Phoenix
- Arizona Center for Cancer Care - Phoenix - Phoenix
- Mayo Clinic Hospital in Arizona - Phoenix
- Arizona Center for Cancer Care - Osborn - Scottsdale
- Arizona Center for Cancer Care - Scottsdale - Scottsdale
- Arizona Center for Cancer Care-Surprise - Surprise
- Arizona Center for Cancer Care - Tempe
Alaska
- Anchorage Associates in Radiation Medicine - Anchorage
- Anchorage Radiation Therapy Center - Anchorage
- Alaska Breast Care and Surgery LLC - Anchorage
- Alaska Oncology and Hematology LLC - Anchorage
- Alaska Women's Cancer Care - Anchorage
- Katmai Oncology Group - Anchorage
- Providence Alaska Medical Center - Anchorage
- Fairbanks Memorial Hospital - Fairbanks
Arkansas
- Mercy Hospital Fort Smith - Fort Smith
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 386 participants |
| Start Date | 2024-04-12 |
| Est. Completion | 2027-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05896189
The ClinicalTrials.gov registry entry for NCT05896189 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 386 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The listed sponsor is NRG Oncology, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Arm 1: Computerized Cognitive Training-Global Stimulation Games is the first listed.
NCT05896189 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Alaska, Arkansas.
Frequently Asked Questions
What is clinical trial NCT05896189 about?
NCT05896189 is a clinical study titled "Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors". This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
What is the current status of trial NCT05896189?
This trial is currently recruiting. It is a NA study. The enrollment target is 386 participants. The study started on 2024-04-12. Estimated completion is 2027-11-30.
What conditions does trial NCT05896189 study?
This clinical trial studies the following conditions: Breast Cancer, Cognitive Impairments.
What interventions are being tested in trial NCT05896189?
The interventions under investigation include: Arm 1: Computerized Cognitive Training-Global Stimulation Games (BEHAVIORAL), Arm 2: Computerized Cognitive Training-Neuroplasticity Games (BEHAVIORAL).
Who is sponsoring clinical trial NCT05896189?
This trial is sponsored by NRG Oncology, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05896189 being conducted?
This trial has 20 study locations across Alaska, Arizona, Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.